GTS Securities’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
GTS Securities's WST Position: Q3 2026 in Review
GTS Securities opened a new position in West Pharmaceutical (WST) in Q3 2026: 566 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #1517 among its holdings. This is a return to the name: GTS Securities previously reported a position in WST as recently as Q4 2025.
GTS Securities first reported a position in WST in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.21M in Q3 2025. 865 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- GTS Securities held 566 shares of West Pharmaceutical worth $210K as of Q3 2026.
- West Pharmaceutical was a new GTS Securities position in Q3 2026.
- West Pharmaceutical made up ﹤0.01% of GTS Securities's portfolio in Q3 2026, its #1517 holding.
- GTS Securities first reported a position in West Pharmaceutical in Q4 2023 and has held it in 6 quarters since.
- GTS Securities's West Pharmaceutical position peaked at $1.21M in Q3 2025.
- 865 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.